The AtlantiCare Board of Trustees didn’t look outside of their own group to find the new Interim President and Chief Executive Officer. Instead, they chose one of their own.
Michael J. Charlton, who used to be Board Chairman and is still on the board, was chosen. He will work closely with Lori Herndon, who is leaving her position as President and CEO.
Herndon is set to leave AtlantiCare on June 30, 2023, after working there for 40 years.
Charlton was Chairman of the Board from 2017 until the beginning of 2023. Since 2009, Charlton has been on the AtlantiCare Board.
Charlton’s work history includes the following:
- Board member of the American Hospital Association.
- Continues to work on national AHA committees.
- Industry experience.
- Wide-ranging entrepreneurial background.
- He attended University of Delaware with a concentration in Finance.
- Obtained B.S. in Healthcare Administration.
- Organizational Leadership from the University of Louisville.
- Completed a Masters degree in Healthcare Leadership from Brown University.
AtlantiCare has made a detailed plan for when Charlton will work with Herndon. Here’s what it says:
They will work together. From May 1 until May 31, 2023, when Herndon steps down from her day-to-day job.
On June 1, 2023, Charlton will become the official interim President and CEO, and Herndon will be available to talk to Charlton until June 30, 2023.
During the formal search for a permanent CEO, Charlton will also work closely with the AtlantiCare Board and the executive team.
Chairman of AtlantiCare’s Board David Goddard said, “Michael is a proven leader who knows a lot about AtlantiCare, the communities we serve, and how healthcare is changing.” “He is also well-known to our team members and other important people in our communities.
He is the perfect person to help our health system make a smooth transition while the Board continues to look for AtlantiCare’s next CEO,” said a spokesperson.